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Summary
 
Chemokines and their receptors are important elements for the selective attraction of various
subsets of leukocytes. To better understand the selective migration of functional subsets of T cells,
chemokine receptor expression was analyzed using monoclonal antibodies, RNase protection
assays, and the response to distinct chemokines. Naive T cells expressed only CXC chemokine
receptor (CXCR)4, whereas the majority of memory/activated T cells expressed CXCR3, and
a small proportion expressed CC chemokine receptor (CCR)3 and CCR5. When polarized T
cell lines were analyzed, CXCR3 was found to be expressed at high levels on T helper cell (Th)0s
and Th1s and at low levels on Th2s. In contrast, CCR3 and CCR4 were found on Th2s. This was
confirmed by functional responses: only Th2s responded with an increase in [Ca
 
2
 
1
 
]
 
i
 
 to the CCR3
and CCR4 agonists eotaxin and thymus and activation regulated chemokine (TARC), whereas
only Th0s and Th1s responded to low concentrations of the CXCR3 agonists IFN-
 
g
 
–inducible
protein 10 (IP-10) and monokine induced by IFN-
 
g
 
 (Mig). Although CCR5 was expressed on
both Th1 and Th2 lines, it was absent in several Th2 clones and its expression was markedly
influenced by interleukin 2. Chemokine receptor expression and association with Th1 and Th2
phenotypes was affected by other cytokines present during polarization. Transforming growth factor
 
b
 
 inhibited CCR3, but enhanced CCR4 and CCR7 expression, whereas interferon 
 
a
 
 inhibited
CCR3 but upregulated CXCR3 and CCR1. These results demonstrate that chemokine recep-
tors are markers of naive and polarized T cell subsets and suggest that flexible programs of
chemokine receptor gene expression may control tissue-specific migration of effector T cells.
 
I
 
t is well established that after activation, T lymphocytes
acquire effector functions that are best exemplified by
the pattern of cytokines produced (1, 2). Th1 effector cells
produce IL-2 and IFN-
 
g
 
 and activate mononuclear phago-
cytes thus protecting against intracellular pathogens. In
contrast, Th2 effector cells produce IL-4 and -5 and are in-
volved in responses dominated by IgE, eosinophils and ba-
sophils.
In addition to effector function, activated T lymphocytes
acquire different migratory capacities, a fact that is the key
to an efficient regulation of the immune response (3). The
regulation of leukocyte migration is an intricate process in-
volving the participation of adhesion molecules such as se-
lectins and integrins (4, 5), as well as chemokines and
chemokine receptors (6). The combined action of adhesion
molecules and chemokines is thought to provide an address
code for leukocyte migration to different sites (7, 8). In-
deed, early work has identified markers for T cell subsets
that preferentially migrate to distinct anatomical sites. Thus,
T cells that home to skin express the cutaneous lympho-
cyte–associated antigen (9), whereas those homing to the
gut express the 
 
b
 
7 integrins (10). In addition to adhesion
molecules, chemokine receptor expression has been shown
to be important for selective leukocyte migration. For in-
stance, expression of the CC chemokine receptor (CCR)3
 
1
 
on eosinophils and the IL-8 receptors on neutrophils allows
these cells to migrate to sites where agonists such as eotaxin
or IL-8 are produced (11, 12).
Presumably, chemokines and chemokine receptors are
also important for the selective migration of T cells, espe-
cially subsets of effector T cells. Indeed, a strong relation-
ship between migratory capacity and cytokine production
is emerging. It was shown recently that Th1s, but not Th2s
express a functional ligand for E- and P-selectin that allows
 
1
 
Abbreviations used in this paper:
 
 CCR, CC chemokine receptor; CXCR,
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monokine induced by IFN-
 
g
 
; MIP, macrophage inflammatory protein;
mRNA, messenger RNA; TARC, thymus and activation regulated
chemokine.
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these cells to migrate to sites of inflammatory reactions (13,
14). In addition, we have shown recently that the eotaxin
receptor CCR3 is expressed on Th2s and not Th1s (15).
These results suggest that migration and effector function
are coordinately acquired as part of a common develop-
mental program.
In this study, we demonstrate that distinct profiles of
chemokine receptors are acquired by T cells after polariza-
tion and are modulated by cytokines. CCR3 and CCR4
are expressed exclusively on Th2s, whereas CXC chemo-
kine receptor (CXCR)3 and CCR5 are preferentially found
on Th0s and Th1s. In addition, TGF-
 
b
 
 inhibits CCR3,
but enhances CCR4 and CCR7 expression, whereas IFN-
 
a
 
inhibits CCR3 and CCR4 but upregulates CXCR3 and
CCR1. These results demonstrate flexible programs of
chemokine receptor gene expression that best serve the
complex requirements for tissue and microenvironment se-
lective migration.
 
Materials and Methods
 
Media and Reagents.
 
The medium used throughout was RPMI
1640 supplemented with 2 mM L-glutamine, 1% nonessential
amino acids, 1% pyruvate, 50 
 
m
 
g/ml kanamycin (GIBCO BRL,
Gaithersburg, MD), 5 
 
3
 
 10
 
2
 
5
 
 M 2-mercaptoethanol (Merk,
Darmstadt, Germany), and 5% human serum (Swiss Red Cross,
Bern, Switzerland) or 10% FCS (Hyclone Laboratories, Inc., Lo-
gan, UT). Human recombinant IL-2 and -4 were produced in
our laboratory by PCR cloning and expression in the myeloma
expression system (16). Eotaxin, IFN-
 
g
 
–inducible protein 10 (IP-
10), monokine induced by IFN-
 
g
 
 (Mig), macrophage inflammatory
protein (MIP)-1
 
b
 
, and thymus and activation regulation chemokine
(TARC) were purchased from Peprotech (London, UK).
 
Cells, T Cell Lines, and Clones.
 
Blood samples were obtained
from healthy volunteers and PBMCs were separated by the stan-
dard Ficoll-paque method. Cord blood T cells were stimulated
with PHA (1 
 
m
 
g/ml; Murex Ltd., Dartford, UK) and rIL-2 (40
U/ml) under Th1-polarizing conditions (human rIL-12 [2 ng/ml;
Hoffmann–La Roche, Nutley, NJ] plus neutralizing mAb to hu-
man IL-4 [200 ng/ml; PharMingen, San Diego, CA]) or Th2-
polarizing conditions (human rIL-4 [200 U/ml] plus neutralizing
mAb to human IL-12 [2 
 
m
 
g/ml; R&D Sys., Inc., Minneapolis,
MN]). After 1 and 2 wk, the cultures were restimulated with
PHA and irradiated allogeneic PBMCs (3,000 rad from a 
 
137
 
Cs
source) in the same polarizing conditions and analyzed after a fur-
ther 10 d. Cell lines were also generated from sorted CD4
 
1
 
 or
CD8
 
1
 
 T cells. In some experiments, IFN-
 
a
 
 (1,000 U/ml; Hoff-
mann–La Roche) or TGF-
 
b
 
1 (2 ng/ml; R&D Sys., Inc.) were
added to Th1- or Th2-polarizing cytokines. T cell blasts were
cloned by limiting dilution and maintained by periodic restimula-
tion with PHA, irradiated allogeneic PBMCs, and rIL-2 as previ-
ously described (17).
 
FACS
 
Ò
 
 Analysis.
 
Cell staining was performed using mAbs
followed by FITC- or PE-conjugated, affinity-purified, isotype-
specific goat anti–mouse antibodies (Southern Biotechnology
Associates, Inc., Birmingham, AL). For three-color analysis bi-
otin-labeled goat anti–mouse antibodies were used followed by
APC-conjugated streptavidin (Molecular Probes, Eugene, OR).
The following mouse antibodies were used: anti-CXCR3 (1C6,
IgG1; reference 18), anti-CCR3 (7B11, IgG2a; reference 19),
anti-CCR5 (5C7, IgG2a; reference 20), anti-CXCR4 (12G5,
IgG2a; R&D Sys., Inc.), anti-CD4 (OKT4, IgG2b and 6D10,
IgG1; American Type Tissue Collection, Rockville, MD), anti–
TCR-
 
a
 
/
 
b
 
 (BM 031, IgG2b), anti-CD45RA (ALB11, IgG1),
and anti-CD45RO (UCHL1, IgG2a) (all from Immunotech,
Marseille, France). Because of the need for three antibodies of
different isotypes in the indirect three-color staining, we used
anti-CD45RO or -CD45RA mAbs to distinguish between naive
and memory T cells. The samples were analyzed on a FACSCali-
bur
 
Ò
 
 (Becton Dickinson, Mountain View, CA) using propidium
iodide to exclude dead cells.
 
Cytokine Detection at the Single Cell Level.
 
T cells were stimu-
lated with 10
 
2
 
7
 
 M PMA plus 1 
 
m
 
g/ml ionomycin (Sigma Chem-
ical Co., St. Louis, MO) for 4 h. Brefeldin A (10 
 
m
 
g/ml, Sigma
Chemical Co.) was added during the last 2 h. Cells were fixed
with 2% paraformaldehyde, permeabilized with phosphate buff-
ered saline containing FCS (1%) and saponin (0.5%) and stained
with FITC-labeled anti–IFN-
 
g
 
 (IgG1) and PE-labeled anti–IL-4
(IgG2b) mAbs (Becton Dickinson).
 
Ca
 
2
 
1
 
 Flux Measurement.
 
T cells were loaded with Indo-1
(Sigma Chemical Co.) and their response to various concentra-
tions of chemokines was analyzed on a FACS Vantage
 
Ò
 
 flow cy-
tometer (Becton Dickinson) as described (21). In some experi-
ments, fluxing and nonfluxing cells were isolated by cell sorting
over a 1-min period and further analyzed for cytokine produc-
tion.
 
RNase Protection Assay.
 
Total RNA was extracted from T
cells using RNAzol B (Tel-Test, Inc., Friendswood, TX). Multi-
probe template sets hCR5 (containing DNA templates for CCR1,
CCR3, CCR4, CCR5, CCR8, CCR2a
 
1
 
b, CCR2a, CCR2b,
and glyceraldehyde-3-phosphate dehydrogenase [GAPDH]) and
hCR6 (containing DNA template for CXCR1, CXCR2, CXCR3,
CXCR4, Burkitt’s lymphoma receptor (BLR)-1, BLR-2/CCR7,
V28, and GAPDH) were purchased from PharMingen. The DNA
templates were used to synthesize the 
 
a
 
-[
 
32
 
P]UTP (3,000 Ci/mmol,
10 mCi/ml; Amersham Life Science, Buckinghamshire, UK)
–labeled probes in the presence of a GACU pool using a T7 RNA
polymerase (Promega, Madison, WI). Hybridization with 5–15
 
m
 
g of each target RNA was performed overnight followed by di-
gestion with RNase A (Boehringer Mannheim, Rotkreuz, Swit-
zerland) and T1 (Calbiochem, La Jolla, CA) according to the
PharMingen standard protocol. The samples were treated by pro-
teinase K (Boehringer Mannheim) –SDS mixture and then ex-
tracted with chloropan and precipitated in the presence of ammo-
nium acetate. The samples were loaded on an acrylamide-urea
sequencing gel next to labeled DNA molecular weight markers
and to the labeled probes, and run at 50 watts with 0.5
 
3
 
 Tris-
borate/EDTA electrophoresis buffer (TBE). The gel was adsorbed
to filter paper, dried under vacuum, and exposed on film (X-AR;
Kodak, Rochester, NY) with intensifying screens at 
 
2
 
70
 
8
 
C.
 
Northern Blot Analysis.
 
10–15 
 
m
 
g of total RNA were loaded
on a RNA formaldehyde denaturing gel and run with 3-[
 
N
 
-mor-
pholino]propane sulfonic acid (MOPS)/EDTA buffer for 3 h,
followed by an overnight transfer to Genescreen membrane
(New England Nuclear, Boston, MA) with 10
 
3
 
 standard saline
citrate (SSC). RNA was covalently fixed to the membrane by
UV cross-linking using Stratalinker (Stratagene, La Jolla, CA).
The membranes were hybridized with either full-length IL-
12R
 
b
 
2 or with 
 
b
 
-actin. The probes were labeled with 
 
a
 
-[
 
32
 
P]dCTP
(Amersham) by random labeling (random primed DNA labeling
kit; Boehringer Mannheim), purified on Biospin 30 spun column
(BioRad Labs., Hercules, CA), heat inactivated, and quenched on
ice before adding to the hybridization mixture. The hybridization
mix was composed by 50% of deionized formamide, 5
 
3
 
 Den- 
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hardt’s, 5
 
3
 
 SSC, 10 mM EDTA, pH 8.0, 1% SDS buffered with
25 mM NaH
 
2
 
PO
 
4
 
, and 25 mM Na
 
2
 
HPO
 
4
 
, and supplemented
with 200 
 
m
 
g/ml heat denaturated salmon sperm DNA (Sigma
Chemical Co.).
 
Results
 
Chemokine Receptor Expression on Naive and Memory T
Cells in Peripheral Blood.
 
Using specific monoclonal anti-
bodies, we analyzed the expression of chemokine receptors
in T cells expressing different CD45 isoforms that identify
naive or memory T cells (22; Fig. 1). CXCR4 was present
at high levels on all cord blood T cells and on CD45RA
 
1
 
adult naive T cells, whereas it was present at lower levels
and only on a fraction (15–40%) of CD45RA
 
2
 
 memory T
cells. In contrast, CCR3, CCR5, and CXCR3 were absent
in cord blood T cells and were expressed preferentially in
adult peripheral blood T cells with memory phenotype.
CCR3 was expressed on a small fraction (1–10%) of
CD45RA
 
2
 
 T cells that has been previously identified to
comprise Th2s (15). CCR5 was expressed on 18–32% of
CD45RA
 
2
 
 T cells, whereas CXCR3 was expressed at high
levels on a much larger fraction (58–73%) of CD45R0
 
1
 
memory T cells. Interestingly, CXCR3 was also present on
a population of CD3
 
1
 
 CD45R0
 
2
 
 cells present in both cord
blood and adult blood. In conclusion, CXCR4 is a major
receptor in naive T cells, whereas CCR3, CCR5, and
CXCR3 are selectively expressed on memory CD45R0
 
1
 
RA
 
2
 
 T cells.
 
Expression of CXCR3, CCR5, and CCR3 after T Cell Po-
larization In Vitro.
 
We have shown that CCR3 is ac-
quired after Th2 polarization in vitro (15). We therefore
investigated whether CXCR3 and CCR5 could be regu-
lated in a similar fashion (Fig. 2). When cord blood T cells
were polarized by two cycles of stimulation in the presence
of the appropriate cytokines, CXCR3, CCR5, and CCR3
were progressively acquired. CXCR3 was expressed at
high levels and on all cells in Th1 lines, whereas it was ex-
pressed at lower levels and with an heterogeneous pattern
in Th2 lines. In contrast, CCR5 expression was variable,
since no consistent preferential expression was evident
from the analysis of several Th1 and Th2 lines. Finally,
CCR3 was expressed on a high proportion of cells in Th2
lines, but on only a few cells in Th1 lines, which indeed
represent contaminating Th2 polarized cells (15). These re-
sults suggest that while CCR3 is a marker of Th2s,
CXCR3 is preferentially expressed on Th0s/Th1s.
 
Reciprocal Modulation of CXCR3 and CCR3 by IFN-
 
a
 
 and
TGF-
 
b
 
.
 
We investigated whether IFN-
 
a
 
 and TGF-
 
b
 
,
which have been shown to affect T lymphocyte polariza-
tion (23, 24), may modulate chemokine receptor expression
when added to Th1- or Th2-polarizing conditions (Fig. 3).
IFN-
 
a
 
 did not show any effect on Th1 polarization.
However, when added to Th2-polarizing conditions, IFN-
 
a
 
induced a shift from Th2 to Th1 as shown by IFN-
 
g
 
 pro-
duction and by upregulation of the IL-12R
 
b
 
2 subunit,
which is a marker of Th1s (23). Interestingly, this treatment
also resulted in an upregulation of CXCR3 and inhibition
of CCR3 expression. These results are compatible with the
notion that IFN-
 
a
 
 is dominant over IL-4 and induces a
complete switch to a Th1 phenotype characterized by ex-
pression of higher levels of CXCR3 and lower levels of
CCR3.
Figure 1. Chemokine receptor expression on naive and memory pe-
ripheral blood T cells. Three-color immunofluorescent staining of mono-
nuclear cells from cord blood (A–E) or adult blood (F–J). Contour plots
represent live cells gated for expression of CD3 (A–D and F–I) or CD4 (E
and J). In different panels, memory T cells are identified as CD45RA2 or
CD45RO1 because of constraints in the choice of antibody isotypes (see
Materials and Methods). Quadrants were set according to the staining of
control mAbs. The CD31 CD45R02 CXCR31 cells were identified as
CD81 cells in separate experiments. Comparable results were obtained
with three additional cord blood and six adult blood samples. 
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T cells polarized under Th2 conditions in the presence
of TGF-
 
b
 
 completely lacked both IL-4 production and
CCR3 expression in keeping with the described effect of
this cytokine on Th2 development (24). However, this was
not accompanied by a switch to Th1, since the cells gener-
ated did not produce IFN-
 
g
 
, expressed low levels of
CXCR3, and lacked the IL-12R
 
b
 
2 subunit.
 
Differential Response to Chemokines by Th1 and Th2
Lines. Polarized T cell lines were tested for their capacity
to respond to chemokines that selectively engage distinct
receptors. Fig. 4 shows the percentage of T cells that un-
dergo [Ca21]i increase in response to various concentrations
of chemokines. Low concentrations of the CXCR3 agonist
IP-10 (25) triggered [Ca21]i increase in Th1 lines, whereas
they were ineffective on Th2 lines. Indeed, Th2 lines re-
sponded only to 10-fold higher concentrations of IP-10,
with a lower percentage of fluxing cells and with a lower
[Ca21]i increase. These results indicate that Th1s have a
higher capacity to respond to IP-10 (and Mig, data not
shown) than Th2s, demonstrating that the level of receptor
expression determines the sensitivity to the agonist. On the
other hand, the CCR5-specific agonist MIP-1b (26, 27)
showed the same effect on Th1s and Th2s, in keeping with
the expression of comparable levels of this receptor on both
cell lines. Finally, the CCR3 agonist eotaxin (28) triggered
[Ca21]i increase in Th2, but not Th1 lines. Interestingly,
TARC, which has been reported to be a selective agonist
for CCR4 (29), efficiently induced a [Ca21]i increase in
Th2, but not Th1 lines, suggesting that the cognate recep-
tor might be selectively expressed on Th2s.
To investigate the relationship between response to
TARC and cytokine production, we stimulated a poly-
clonal Th2 line with TARC, sorted the fluxing cells, and
measured cytokine production after stimulation with PMA
and ionomycin. As shown in Fig. 5, the TARC-responsive
population was highly enriched in Th2s and depleted in
Th1s and Th0s, demonstrating that the TARC receptor is
expressed on Th2s.
CCR4 Is Preferentially Expressed on Th2s, whereas CCR1
and CCR7 Are Upregulated by IFN-a and TGF-b, Respec-
tively. To corroborate the above results on CCR4 ex-
pression and to extend the analysis to chemokine receptors
for which antibodies were not available, we performed
RNase protection assays on Th1 and Th2 lines generated in
the absence or in the presence of TGF-b or IFN-a (Fig. 6).
As expected from the above results, CXCR4 and CCR5
messenger RNAs (mRNAs) were present at comparable
levels in Th1 and Th2 lines, whereas CXCR3 mRNA was
more abundant in Th1 and CCR3 mRNA was present at
much higher levels in Th2 lines. In addition, lines obtained
in the presence of TGF-b or IFN-a showed changes in
CCR3 and CXCR3 mRNAs that were consistent with
those observed using mAbs.
Remarkably, CCR4 mRNA was expressed at high lev-
els in Th2 lines and was virtually absent on Th1 lines. In
addition, CCR4 was upregulated by TGF-b and downreg-
Figure 2. Acquisition of
CXCR3, CCR5, and CCR3 af-
ter T cell polarization in vitro.
Cord blood T cells were acti-
vated for two consecutive cycles
under Th1- (IL-12 1 a–IL-4) or
Th2- (IL-4 1 a–IL-12) polariz-
ing conditions. The cells were
analyzed for IFN-g and IL-4
production by intracellular stain-
ing (dot plots in a four-decade
logarithmic scale) and for expres-
sion of chemokine receptors
(histograms in a four-decade log-
arithmic scale) 10 d after the first
polarization (A) and 10 d after the
second polarization (B). Compa-
rable results were obtained in
three additional experiments.879 Sallusto et al.
ulated by IFN-a. Taken together with the selective re-
sponse of Th2s to TARC, these data indicate that CCR4,
like CCR3, is selectively expressed on Th2s. However,
CCR4 is regulated differently from CCR3 in response to
TGF-b.
Two receptors were expressed similarly on Th1s and
Th2s, but were differentially modulated by IFN-a and
TGF-b. CCR1 was expressed at low levels in Th1s and
Th2s polarized under standard conditions. Addition of
IFN-a resulted in a dramatic increase in CCR1 message,
whereas addition of TGF-b resulted in an almost complete
inhibition. In contrast, CCR7 was absent in Th1 and Th2
lines, but its expression was strongly upregulated by TGF-b.
Taken together, the above results indicate that IFN-a
and TGF-b can add further functionality to polarized T
cells by modulating the expression of chemokine receptors.
Chemokine Receptor Expression on T Cell Clones. A large
panel of T cell clones were analyzed for IL-4 and IFN-g
production and for chemokine receptor expression. Three
examples are shown in Fig. 7, A–C. In general, clonal pop-
ulations showed a considerable heterogeneity in the pattern
of cytokine production, since they comprised cells that did
not make any cytokine as well as cells that made all the pos-
sible combinations of IFN-g and IL-4. Indeed, even typical
Th1 or Th2 clones contained a few cells that produced the
reciprocal cytokine combination. The expression of CXCR3
and CCR3 on individual clones reflected their expression
on polyclonal lines. CCR3 was expressed only by Th2
clones, whereas CXCR3 was expressed at higher levels on
Th1 than on Th2 clones, with few exceptions (Fig. 7 D).
In contrast, CCR5 expression on T cell clones was variable
since the receptor was absent on several (but not all) Th2
clones (Fig. 7 E). In addition, CCR5 expression was influ-
enced by the activation state and by the presence of IL-2.
Indeed, IL-2 withdrawal for 4 d resulted in a complete loss
of CCR5 expression, whereas CXCR3 or CCR3 were re-
tained (data not shown).
Discussion
We have shown that after activation, T cells acquire new
chemokine receptors as they develop into memory/effector
Figure 3. Modulation of IFN-g and IL-4 production and CCR3 and CXCR3 expression in polarized T cell lines by TGF-b and IFN-a. Cord blood
T cells were polarized by two consecutive cycles of stimulation in the presence of IL-12 1 a-IL-4 (Th1) or IL-4 1 a-IL-12 (Th2) alone or together with
TGF-b or IFN-a. (A) IFN-g and IL-4 production at the single cell level measured by intracellular staining (four-decade logarithmic scale); (B) CCR3
and CXCR3 expression (four-decade logarithmic scale); (C) IL-12Rb2 mRNA expression as determined by Northern blot on total RNA using as probe
the full-length human IL-12Rb2 subunit cDNA. Exposure time was 7 d using an intensifying screen at 2708C. Two major messages were found as de-
scribed (42). As a loading control, the blot was stripped and rehybridized for b-actin.880 Chemokine Receptor Expression on Polarized T Lymphocytes
cells. In particular, Th1s and Th2s (generated under the in-
fluence of IL-12 and -4, respectively) express distinct pat-
terns of chemokine receptors, which can be further modu-
lated by IFN-a and TGF-b.
CXCR4 is expressed at high levels on cord blood T cells
and on adult peripheral blood CD45RA1 naive T cells, but
is expressed at lower levels on adult CD45RA2 memory T
cells, and is even absent on some of them. In addition,
while CXCR4 is expressed on short-term T cell lines and
is even upregulated by stimulation with IL-2 and PHA
(20), it was absent on most long-term T cell clones (data
not shown). Taken together, these results suggest that
CXCR4 is progressively lost after repeated antigenic stim-
ulations.
We have previously shown that CCR3 is selectively ex-
pressed on Th2s (15), and in this work, we identify CCR4
as an additional Th2-specific marker. Th2 lines express
high levels of CCR4 message and undergo [Ca21]i increase
in response to TARC, a selective ligand for CCR4 (29). In
addition, T cell responsiveness to TARC can be used to di-
rectly isolate an almost pure population of Th2s from cell
lines that contain mixed populations of Th1s, Th0s, and
Th2s. Interestingly, CCR4 is also expressed on basophils,
while CCR3 is expressed on both eosinophils and baso-
phils (19, 30, 31). The sharing of chemokine receptors be-
tween Th2 and the effector cells of allergy is likely to rep-
resent a key mechanism for the generation of allergic
Figure 4. Differential response to chemokines of Th1 and Th2 lines.
(A and B) Time course of [Ca21]i increase in Th1 (A) and Th2 (B) T cell
lines stimulated with 100 ng/ml IP-10. (C) Percent of fluxing cells in Th1
(open circles) and Th2 (closed circles) lines stimulated with various concentra-
tions of the indicated chemokines. The percentage of fluxing cells was
calculated cumulatively over a 1-min period after the addition of
chemokine. Comparable results were obtained with two additional cell
lines as well as with several T cell clones.
Figure 5. TARC-responsive cells are Th2. (A) A polyclonal Th2-
polarized cell line was loaded with Indo-1 and challenged with 100 ng/ml
TARC. Fluxing and nonfluxing cells were sorted over a 1-min period.
Unsorted (B), and sorted fluxing (C) and nonfluxing (D) T cells were
stimulated with PMA 1 ionomycin for 4 h and IFN-g and IL-4 were
measured by intracellular staining.
Figure 6. CCR4 is preferentially expressed on Th2s and CCR1 and
CCR7 are upregulated by IFN-a and TGF-b. Chemokine receptor mes-
sage was determined by RNase protection assay using the multiprobe
template sets hCR5 (A) and hCR6 (B, see Materials and Methods). T cell
lines generated under Th2- or Th1-polarizing conditions in the absence
or in the presence of TGF-b or IFN-a were analyzed. The results are
representative of one out of three experiments with consistent results.
The upregulation of CCR7 in cultures supplemented with IFN-a was
not reproduced in other experiments.881 Sallusto et al.
reactions. CCR3 and CCR4 ligands may selectively attract
not only eosinophils and basophils, but also Th2s that,
upon activation by antigen, could provide a source of IL-4
and IL-5 required for activation and survival of the effector
cells (15).
CXCR3 is selectively expressed on lymphocytes and
binds the IFN-g–induced chemokines IP-10 and Mig (25).
We have shown that CXCR3 is present on most peripheral
blood CD45R01 T cells and is expressed at higher levels
on Th0s and Th1s and at low levels on Th2s. The respon-
siveness to IP-10 and Mig, together with the expression of
ligands for E- and P-selectin (13), may favor the migration
of Th1 and Th0 cells to sites of inflammatory reaction
dominated by IFN-g production (32).
CCR5 is a receptor for regulated on activation normal T
cell expressed and secreted (RANTES), MIP-1a and MIP-
1b (27) and was expressed at comparable levels on Th1 and
Th2 lines. However, when clones were analyzed, CCR5
appeared to be expressed at higher levels on Th1, whereas
many Th2 clones were negative. One should note that CCR5
expression is influenced by the activation state of the T
cells and, as other receptors (33), is upregulated by IL-2
(20). Thus, while CXCR3 is expressed as a stable marker
of memory Th1s and Th0s, CCR5 reflects the activation
state of the cells. This may be the reason why CCR5 is
present on fewer peripheral blood memory T cells than
CXCR3.
IFN-a and TGF-b have a major influence on Th1/Th2
polarization and also affect the expression of chemokine re-
ceptors. It has been shown that in humans, IFN-a, and
similarly IL-12, induce signal transducer and activator of
transcription 4 (STAT4) phosphorylation (34) and conse-
quently dominantly induce Th1 differentiation (23). We
have shown that when added to Th2-polarizing conditions
(IL-4 plus anti–IL-12 antibodies) IFN-a not only reverts
the cytokine profile from Th2 to Th1, but also the
chemokine receptor profile, since it prevents the acquisi-
tion of CCR3 and CCR4 and allows expression of high
levels of CXCR3. In addition, IFN-a upregulates CCR1
expression in all polarizing conditions, thus conferring ad-
ditional properties to Th1s besides those induced by IL-12.
TGF-b has been reported to inhibit Th2 development
and maintain T cells in a state close to naivety (24). We
have shown that TGF-b indeed prevents the development
of the IL-4–producing phenotype, as well as CCR3 ex-
pression. However, the expression of CCR4 is not inhib-
ited, but rather enhanced by TGF-b, indicating that
CCR3 and CCR4, although both expressed on Th2s, are
differentially regulated. Thus, only CCR3 represents a reli-
able marker for Th2s, since it correlates precisely with the
acquisition of the IL-4–producing phenotype. On the
other hand, CCR4, although expressed on Th2s, does not
appear to be a selective Th2 marker since it is also ex-
pressed on cells that are not capable of producing IL-4.
In addition to upregulating CCR4, TGF-b also upregu-
lates CCR7, a receptor specific for EBV-induced gene 1
(EBI1) ligand chemokine (ELC)/MIP-3b (35). Further-
more, CCR7 was also found on CD45RA1 naive T cells
by RNase protection (F. Sallusto, unpublished data). It is
interesting to speculate that T cells activated under the ae-
gis of TGF-b may be in a particular “seminaive” state char-
acterized by low effector function combined with the ca-
pacity to migrate to secondary lymphoid organs in response
to the cognate chemokines ELC/MIP-3b to complete
their education.
Our studies suggest that chemokine expression will be a
central factor controlling the type of T cell immune re-
sponse in a tissue, for instance, Th1 or Th2. Expression of
the CXCR3 ligands IP-10 or Mig would lead to a prefer-
ential Th1 recruitment, whereas expression of CCR3 or
CCR4 ligands such as eotaxin and TARC would lead to
preferential Th2 recruitment. The regulation of chemokine
expression is still poorly understood. IP-10 and Mig are in-
duced by IFN-g (36) and IP-10 is found at sites of Th1
type immune responses and delayed-type hypersensitivity
reactions (32). Eotaxin is induced in Th2 type immune re-
sponses, such as in allergic airway disease, but is largely ab-
sent from arthritic lesions (12; and Mackay, C.R., unpub-
lished data).
Besides their role in leukocyte migration, some chemo-
Figure 7. Chemokine receptor expression on T cell clones. (A–C)
IFN-g and IL-4 production and chemokine receptor expression (both on
four-decade logarithmic scale) on three representative Th0, Th1, and Th2
clones; (D) CXCR3 expression level and (E) percent of CCR51 cells in
Th0, Th1, and Th2 clones. The mean and standard deviation for each
group is also shown. No direct correlation was found in the expression of
CXCR3 and CCR5. T cell clones were defined according to cytokine
profile (Th0, IFN-g and IL-4; Th1, IFN-g and no IL-4; Th2, IL-4 and
no IFN-g).882 Chemokine Receptor Expression on Polarized T Lymphocytes
kine receptors such as CXCR4, CCR5, and CCR3 be-
have as coreceptors for HIV entry into target cells (37–40).
The differential expression of these receptors on naive and
polarized T cells will determine their susceptibility to be
infected by viruses carrying different surface glycoproteins.
It is interesting that the CC chemokine macrophage-derived
chemokine (MDC) has been recently shown to be a pow-
erful and broad spectrum inhibitor of HIV infection, rais-
ing the possibility that the cognate receptor, CCR4, plays a
major role as a coreceptor for viral entry (41). We have
shown that both CCR3 and CCR4 are expressed on Th2s
and that CCR4 is upregulated on all cells by TGF-b. In
addition, CCR4 is expressed also on peripheral blood mem-
ory T cells at high levels (F. Sallusto, unpublished data).
In conclusion, our data show that chemokine receptor
expression on T cells is controlled by activation and cyto-
kines present in the milieu and correlates with distinct ef-
fector function. The expression of chemokine receptors is
not only a useful marker of polarized T cells and a tool to
study T cell differentiation, but also a possible target to in-
terfere with an immune response by inhibiting the recruit-
ment of distinct functional subsets.
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